Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Targeting Signaling Pathways in Multiple Myeloma

Author(s): Cavallo Federica, Palumbo Antonio, Tricot Guido and Boccadoro Mario

Volume 7, Issue 6, 2006

Page: [407 - 413] Pages: 7

DOI: 10.2174/138920106779116883

Price: $65

Abstract

Multiple myeloma (MM) is an incurable malignancy of terminally differentiated B-cells accounting for approximately 1 to 2% of all human cancers. The development of MM is believed to be a multistep transformation process that leads to progressive accumulation of genetic alterations. The interaction between MM and bone marrow (BM) microenviroment triggers multiple proliferative and antiapoptotic signaling pathways. Here we discuss the current understanding of signaling pathways, and their potential implication in targeted therapies in MM.

Keywords: Interleukin-6, VEGF, MAPK signaling pathways, Bcl-2 homology, Post Transcriptional Pathways


Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy